International Journal of Pharmaceutical Sciences and Drug Analysis
  • Printed Journal
  • Refereed Journal
  • Peer Reviewed Journal

P-ISSN: 2788-9246, E-ISSN: 2788-9254
Printed Journal   |   Refereed Journal   |   Peer Reviewed Journal

2021, Vol. 1, Issue 2, Part A

Medicinal plants as good source for treatment of COVID-19: A short review


Author(s): Khaled Rashed

Abstract: The search to identify treatments and vaccines for novel coronavirus disease (COVID-19) are ongoing. There are some selected medicinal plants (Nigella sativa, Vernonia amygdalina, Azadirachta indica, Eurycoma longifolia and others), with reported antiviral, anti-inflammatory, and immunomodulatory effects that might be interesting for further investigation. Results proved that A. indica reported positive antiviral evidence specific to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on preliminary in silico data while the other medicinal plants proved differential anti-inflammatory or immunomodulatory effects. Quality control and standardisation of medicinal plant-based products also needs to be emphasized. However, given the unprecedented challenges faced, ethnopharmacological research should be given a fair amount of consideration for contribution in this pandemic.

Pages: 27-30 | Views: 860 | Downloads: 316

Download Full Article: Click Here

International Journal of Pharmaceutical Sciences and Drug Analysis
How to cite this article:
Khaled Rashed. Medicinal plants as good source for treatment of COVID-19: A short review. Int J Pharm Sci Drug Anal 2021;1(2):27-30.
International Journal of Pharmaceutical Sciences and Drug Analysis
Call for book chapter